Exabis Library
Welcome to the e-CCO Library!
DOP19 Real-world healthcare resource utilisation among patients with inflammatory bowel disease administered vedolizumab for 6 months
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP19: Myeloid and lymphoid cell abnormalities persist in the intestinal mucosa of patients who recover from COVID-19 infection
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP19: Spermidine treatment ameliorates experimental colitis in vivo
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP19: Urinary metabolome in newly diagnosed treatment-naïve Crohn’s Disease patients: Results from the IBDomics study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP20 Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP20: Drugs that modulate histone acetylation disrupt TGF-β-signalling and reduce collagen I expression in models of stricturing Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP20: Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD Consortium
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP20: Genetic of vitamin D as predictor of response to adalimumab in Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP21 Time to first treatment with biologic agents for ulcerative colitis and Crohn’s disease across four Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP21: Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP21: Role of P2X7 in intestinal fibrosis and inflammasome activation: Relevance in Crohn´s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP22 Certification of integral care IBD Units: Evaluation of a certification program (CUE)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP22: Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP22: Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP23 Endoscopic evaluation at 1 month after ileocolic resection for Crohn’s disease predicts postoperative recurrence and is safe
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM